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Abstract
Histamine	receptors	(nomenclature	as	agreed	by	the	NC-IUPHAR	Subcommittee	on
Histamine	Receptors	[80,	173])	are	activated	by	the	endogenous	ligand	histamine.	Marked
species	differences	exist	between	histamine	receptor	orthologues	[80].	The	human	and	rat	H3
receptor	genes	are	subject	to	significant	splice	variance	[12].	The	potency	order	of	histamine	at
histamine	receptor	subtypes	is	H3	=	H4	>	H2	>	H1	[173].	Some	agonists	at	the	human	H3	receptor
display	significant	ligand	bias	[182].	Antagonists	of	all	4	histamine	receptors	have	clinical	uses:	H1
antagonists	for	allergies	(e.g.	cetirizine),	H2	antagonists	for	acid-reflux	diseases	(e.g.	ranitidine),	H3
antagonists	for	narcolepsy	(e.g.	pitolisant/WAKIX;	Registered)	and	H4	antagonists	for	atopic
dermatitis	(e.g.	adriforant;	Phase	IIa)	[173]	and	vestibular	neuritis	(AUV)	(SENS-111	(Seliforant,
previously	UR-63325),	entered	and	completed	vestibular	neuritis	(AUV)	Phase	IIa	efficacy	and	safety
trials,	respectively)	[216,	8].
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